A Phase I study of MAX-40279 given orally to patients with acute myelogenous leukemia (AML)

Project: Research

Project Description

NMA HREC Reference Number: HREC/18/SVH/97
NMA SSA Reference Number: SSA/18/MonH/489
Monash Health Ref: RES-18-0000-385X
StatusActive
Effective start/end date13/08/19 → 12/08/24
View all
View less

Keywords

  • clinical trial
  • phase 1 study
  • treatment efficacy
  • leukemia